BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 331615)

  • 1. Primary aldosteronism.
    McGuffin WL; Gunnells JC
    Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary aldosteronism.
    Swanson MR; Fish JC
    Tex Med; 1977 Dec; 73(12):60-3. PubMed ID: 594918
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis due to primary hyperaldosteronism.
    Martínez JJ; Oliveira CL; Meneses AL; Rodríguez SA; Corrales PP; López AH; Romero FB
    Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Normokalemic primary hyperaldosteronism].
    Vonend O; Rump LC
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H24-7. PubMed ID: 17109245
    [No Abstract]   [Full Text] [Related]  

  • 8. [A 54-year-old patient with muscle weakness, hypokalemia and arterial hypertension].
    Arnold G; Schüle B; Mörl H
    Internist (Berl); 1988 Oct; 29(10):697-9. PubMed ID: 3069781
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma.
    Burke M; Papo J; Stavorovsky M; Almog C
    Postgrad Med; 1984 Aug; 76(2):173, 176-8. PubMed ID: 6462970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of primary aldosteronism].
    Wang GY
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 30(11):677-9, 700. PubMed ID: 1307299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary aldosteronism due to adrenocortical adenoma (Conn's syndrome).
    Stein L; Shapiro N; Stein D
    S Afr Med J; 1966 Nov; 40(41):993-6. PubMed ID: 5955092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
    Herpin D; Sosner P; Amar J; Chamontin B
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestation of aldosteronoma.
    Al Fehaily M; Duh QY
    Surg Clin North Am; 2004 Jun; 84(3):887-905. PubMed ID: 15145241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of primary hyperaldosteronism].
    Hodler J
    Schweiz Med Wochenschr; 1972 Jul; 102(30):1039-44. PubMed ID: 4572955
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of primary and secondary aldosteronism].
    Nishikawa T; Saito J
    Nihon Rinsho; 2006 May; Suppl 1():621-3. PubMed ID: 16776232
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
    Horton R
    Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperaldosteronism with coexistence of adrenal cortical adenoma and pheochromocytoma.
    Hsieh BS; Chen FW; Hsu HC; Chang CC; Chen WY
    Taiwan Yi Xue Hui Za Zhi; 1979 May; 78(5):455-51. PubMed ID: 288840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary aldosteronism--hypertension associated with hypokalemia and reduced plasma renin activities].
    Takatsu T; Hasegawa H; Kubo S; Tanaka T; Kitaura Y
    Nihon Rinsho; 1975 Nov; 33(11):3248-60. PubMed ID: 1239554
    [No Abstract]   [Full Text] [Related]  

  • 20. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.